GLP-1 RA injectable use prevalence among adults with diabetes was 26.5% in 2024, but rates were higher in some age and racial groups.

Certain gut bacterial taxa appear to be reciprocally linked with risk for insomnia, and the Odoribacter genus shows a causal effect.

Very or extremely bothersome symptoms are down compared with 10 years ago, but predicting symptoms remains elusive.